Ligand validation:5RC9

RD4: 3-ethoxybenzene-1-carboximidamide

RD4 is a Ligand Of Interest in 5RC9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5RC9_RD4_A_403	44%	33%	0.131	0.856	0.97	1.66	1	2	2	0	100%	0.25
5RC9_RD4_A_402	27%	76%	0.14	0.787	0.55	0.41	-	-	1	0	100%	0.25
5RC9_RD4_A_401	23%	67%	0.174	0.798	0.5	0.76	-	-	0	0	100%	0.25
5R27_RD4_A_402	4%	78%	0.465	0.85	0.42	0.46	-	-	0	0	100%	0.38
8CFR_RD4_A_503	35%	22%	0.144	0.831	1.98	1.31	3	1	0	0	100%	1
7I1E_RD4_A_402	9%	20%	0.263	0.758	1.45	1.92	3	2	0	0	100%	0.26

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.